Senior Vice President, Head of Portfolio Strategy & Operations, Pioneering Medicines
Alec joined Pioneering Medicines in 2020 and is responsible for building Pioneering Medicines’ operations model and portfolio strategy focused on delivering innovative therapies for patients.
He has years of global industry expertise in shaping and executing asset strategies, focusing capital on the highest value programs, and strengthening critical organization capabilities to drive programs. He is a proven leader with a strong understanding of operational, clinical, and regulatory requirements as well as business and financial management skills.
Prior to joining Pioneering Medicines, Alec spent more than 12 years at Celgene, with senior roles including Corporate Vice President of Global Project Leadership responsible for late-stage development projects in hematology-oncology and inflammation-immunology and as a member of the company’s Development Committee. He previously served as the global project leader for Revlimid in Multiple Myeloma, the company’s flagship therapy, and was on the founding leadership team of Celgene China. Prior to Celgene, Alec worked at the U.S. Treasury, The Carlyle Group and Morgan Stanley.
Alec received his M.B.A. from the University of Virginia Darden Graduate School of Business and his A.B. in Politics from Princeton University.